VNS Treatment for Epilepsy and TRD

The Hardy Center for
 Functional Medicine

The Hardy Center for Developmental &
Neuropsychiatric Disorders

Research at Hardy Healthcare

 
 

Our Philosophy


 

Our Staff


 

Dr. Hardy's CV


 

General Information


 

Financial Policy


 

References


 

Directions


 

Forms


 

 

 

 

 




 

 

 

The Hardy Center for Autism, Developmental Disabilities & Neuropsychiatric Disorders

“To affect the quality of the day is the highest art.”

Henry David Thoreau

The Hardy Center for Developmental & Neuropsychiatric Disorders

Pervasive Developmental Disorders:

 
Autism, Asperger's Syndrome, PDD–NOS (Pervasive Developmental Disorder-Not Otherwise Specified), Rett's Syndrome:
 
  • Differential Diagnosis
  • Diagnosis & Treatment with a special emphasis on nutrition, metabolic functioning & neuro-psychopharmacology
  • The DAN! Protocol
  • Secretin Therapy
  • Heavy Metal Toxicity
  • Gastrointestinal Disorders associated with Autism
 
Neuropsychiatric Disorders associated with Developmental Disorders:
 
  • Downs Syndrome
  • Prader-Willi Syndrome
  • Mitochondrial Disorders
  • Chromosomal Disorders
 
Behavioral & Psychiatric Disorders associated with Epilepsy
   
 

Neuropsychiatric Disorders:

 
ADD / ADHD:
 
  • Sub-types that respond poorly to stimulants & Other types of medications
  • Sub-types that are related to diet, food dyes, or to Environmental agents
  • Sub-types that are related to co-existing disorders
 
Anxiety Disorders
 
  • Obsessive-Compulsive Spectrum of Disorders
  • Social Anxiety Disorder – persistent fear of social situations
  • Panic Disorder- panic attacks, agoraphobia
  • Generalized Anxiety Disorder- free-floating anxiety
  • Body Dysmorphic Disorder – preoccupation with an imagined defect in appearance
  • Specific or Multiple Phobias
  • School Anxiety
 
Mood Disorders
 
  • Dysthymia – "chronic low-grade foul mood”
  • Cyclothymia – mild form of Bipolar Disorder
  • Major Depression – severe sadness with inability to take pleasure in anything
  • Bipolar Disorder
    • Type I: At least one Manic episode
    • Type II: Recurrent Major Depression with Mania or Hypomania
  • Treatment-resistant Mood Disorders
 
Tic Disorders
 
  • Tourette Disorder
  • Chronic Motor or Vocal Tic Disorder
  • Transient Tic Disorder
 
Special Category
 
  • “Been everywhere, done everything, nothing has really helped”
  • “Falling between the cracks” of the medical specialties:  Pediatrics, Neurology, Immunology, Psychiatry, etc.

Background & Interests 

Dr. Hardy’s interest in autism and developmental disorders dates back to his fellowship in medical ethics sponsored by the Joseph P. Kennedy Jr. Foundation in 1976-1977.  This fellowship led to his first position with the Eunice Kennedy Shriver Center in Waltham, Massachusetts where he served as a neurologist at both the Paul A. Denver State School and the Walter E. Fernald State School in Massachusetts.  During this time he was exposed to a wide variety of developmental disabilities including severe forms of mental retardation, chromosomal disorders, metabolic disorders, as well as a wide variety of patients with autism. 

During those early years of his career Dr. Hardy developed a subspecialty in the neuropsychopharmacology of autism and the developmental disabilities.  It was also during this time that he worked under Dr. Raymond Adams at the Massachusetts General Hospital and the Harvard Medical School Department of Neurology.  In 1980 Dr. Hardy moved over to the Tufts University School of Medicine, joining the Departments of Neurology and Psychiatry, where he specialized in treating both children and adults with developmental disabilities, epilepsy with comorbid behavioral disorders, and persons with acquired brain injury.

In 1992 Dr. Hardy left Tufts University School of Medicine to form Hardy Healthcare Associates in order to expand his clinical interests in Behavioral Neurology/Neuropsychiatry, especially the Developmental Disabilities, for all age groups.

Defeat Autism NOW! (DAN!)

In 1997 Dr. Hardy attended his first DAN! Conference at the urging of several mothers of children with autism who had witnessed significant improvements in their children by placing them on dairy-free and/or wheat-free diets.  He was quite skeptical as he flew out to the conference in San Diego, CA but it turned out to be a practice-altering experience.  Upon returning to his practice he was truly overwhelmed by the relevance of DAN! concepts for helping to improve the lives of children with autism. 

Since that first conference, Dr. Hardy notes he has learned more basic medicine than he had learned during his medical school years, residency, and fellowship training.  What has been especially important has been learning to practice a truly integrative and functional approach to healthcare, no longer considering and treating each organ system as a separate entity.  Although the DAN! approach remains extremely controversial in the minds of many clinicians and researchers, it has been gratifying to see how month by month, year after year, many DAN! ideas and treatments are being accepted and adopted by the mainstream medical community, as well as by parents who are the final consumers in this free marketplace of ideas and meaningful care.  Dr. Hardy continues to believe that what Bernard Rimland, Ph.D. has created will prove to be one of the most significant developments for autism since Dr. Leo Kanner first described autism.

Dr. Rimland’s website:  http://www.autismwebsite.com/ari/index.htm

The DAN! website:  http://www.autismwebsite.com/ari/dan/dan.htm

A New Conceptualization of Autism

            Traditional Concepts:  Originally, autism was thought to be a psychological disorder emanating from bad parenting.  However, in recent years autism has been thought to be a brain disorder, or neurological disorder, strongly determined by genetic factors beginning in utero or shortly after birth.  This concept has focused medical research on a search for ‘the gene’ or ‘genes’ causing autism and has led to a therapeutic nihilism in medicine over the past fifteen years, with the exception of behavioral and educational interventions.

            Genes vs. Environment:  It is true that autism is the most strong of the genetically-determined developmental behavioral disorders, or psychological disorders, with a heritability rate of 0.90 in identical twins.  This led to the belief that there was one gene responsible for autism, or at most a hand full of genes.  After fifteen years of searching for the gene, or genes, and the expenditure of untold millions of dollars, no single gene, or set of genes, has been found.  Possible gene loci have been identified but what is very clear is that autism is a polygenetic condition with the environment probably playing a significant role in the expression of genetic factors.  It is no longer genes vs. environment. It is genes and environment!

            The Latest Research:  Just within the past two years there have been several important research papers published which are creating a paradigm shift in concepts about autism.  The first area has been that of gastrointestinal dysfunction in autism.  The second has been a growing realization that, in autism, the immune system is quite abnormal and that neuroinflammation may play a major role in the development of autism.  The third area concerns detoxification and the emerging findings that many children with autism have impaired detoxification which, in turn, leads to significant oxidative stress in the brain.  Thus the shift, in autism, is to think not only of the brain but to think in terms of an ‘Autism Quadrangle’.

            The Autism Quadrangle of System Involvement:  This exciting concept of thinking about autism as an interconnected and interdependent quadrangle is that it can, not only, guide and improve research but it also provides for new treatment options for autism.  Many existing treatments that are presently available for gastrointestinal dysfunction, immune dysfunction, and detoxification dysfunction, now become available for use in autism by virtue of thinking and practicing systemically. To conceptualize this, Dr. Hardy has developed the following diagram to help portray the dynamic, synergistic, and interdependent features of autism.

Gastrointestinal System:  40 – 50 % of children with autism have major bowel problems characterized by chronic constipation, chronic diarrhea, or alternating combinations of both.  Historically, this has been referred to as ‘the constipation of autism’ or ‘the diarrhea of autism’ with little thought given to causation or treatment.  There are a number of reasons why children with autism have these problems and many of the conditions are treatable, if properly identified.  Treatment of the gastrointestinal tract can lead to a reduction in the severity of the autism for reasons that will be made clear in the next section.  Also, because the gastrointestinal dysfunction leads to malnutrition in autism, the evaluation of nutrition and the correction of nutritional deficiencies can improve the symptoms of autism: behavior, socialization, learning, etc.

Immune System:  Increasingly over the last fifteen years, immune system abnormalities have been discovered in autism.  The most significant advance in this field came when a publication, in January 2005, demonstrated that the brains of children with autism, who suffered accidental death, have significant signs of neuroinflammation.  What is important to realize is that nearly 70% of the immune system surrounds the intestinal tract (Gastrointestinal Associated Lymphoid Tissue, GALT) and is directly affected by the health of the gastrointestinal system.  It is now understood that the bacterial ecology within the lumen of the intestine helps to regulate the GALT.  The GALT, in turn, has communicating effects upon other organ systems within the body such as the skin and the brain.  By treating the immune dysfunction, one can beneficially impact the degree of symptoms and signs of the autism.

Detoxification System:  The detoxification system of the body has not been well studied in autism until very recently.  Several recent studies suggest that children with autism cannot efficiently detoxify foreign substances such as pesticides and heavy metals.  Therefore, these poisons gradually accumulate in the children adversely affecting proteins, enzymatic functioning, and producing oxidative stress.  By trying to correct these abnormal detoxification pathways, one can lower the toxic burden and oxidative stress in the bodies of children with autism.  In turn, the signs and symptoms of autism can be improved.

Nervous System:  Dysfunction in the gastrointestinal system, immune system, and detoxification system individually, and collectively, adversely impact the nervous system producing the signs and symptoms of autism.  At this time there are no specific medical treatments for the neurological dysfunction in autism.  Therefore, one must rely on treatment of the other systems.  This is the cornerstone of the DAN! approach for treating autism.

The Genome:  The genetics of autism are far more complex than has generally been recognized.  The discoveries of the recently completed Human Genome Project reveal that many genes have variations in form which are referred to as single nucleotide polymorphisms (SNPs) or ‘snips’.  Some genes can have multiple polymorphisms, further multiplying the permutations and combinations of genes.  This great complexity is the reason the genetic research to date has been so disappointing.

The Environment:  The environment interacts with genes and SNPs to produce many of the diseases an individual may experience in life, and this is true for autism as well. This may explain the variations in the forms of autism that children develop, and that we have all struggled to understand.  Increasingly, it is the various toxins in our environment are thought to contribute to the types of autism we see (phenotypes).

The Phenotypes of Autism:  Phenotype means the type we can see or observe.  Because of the great variations in biologic individuality, there are actually many phenotypes of autism.  Each person with autism, in a sense, is unique and should be evaluated and treated as such.  The failure of many research studies in autism is, in Dr. Hardy’s opinion, the failure to properly sub-classify the phenotypes of autism.

Methodology and Hierarchy of Assessment

The evaluation of a person with autism is similar to peeling away layers of an onion.  The initial evaluation which includes a detailed history, the review of previous records, and a physical examination determines where to begin the process.  Often, a thorough evaluation of gastrointestinal functioning is the first layer to consider.  This next layer may be immune function, or an evaluation of detoxification and oxidative stress.  This may be followed by a thorough evaluation of the brain:  radiological imaging studies and electrophysiological studies.  In many cases, it is not until the gastrointestinal system is treated adequately that other systems can be effectively treated. 

Treatment

The biological treatments of autism are many, and they are often interdependent: one affecting the other and dependant on the other.  The latest version of the DAN! treatment guide, AUTISM: EFFECTIVE BIOMEDICAL TREATMENTS (2005) goes into considerable detail about the rationale and specific implementation of these many treatments.  An overview of these treatments in the context of the Autism Quadrangle is depicted as follows:

Applicability to a wide range of disorders

This approach to evaluating and treating autism, the severest of the developmental disorders, has applicability to many other developmental disorders such as Down’s syndrome, Rhett’s syndrome, Praeder-Willi syndrome, and even individuals with epilepsy.  Nutritional issues and bowel problems are common in many developmental conditions.

 


Send mail to webmaster with questions or comments about this web site.
Copyright © 2000-2008 Hardy Healthcare Associates, P.C.
Last modified: Friday, July 14, 2006